Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients:: Comparison of clinical features and review

被引:73
作者
Tee, W
Mijch, A
机构
[1] Western Hlth Care Network, Victorian Infect Dis Reference Lab, Fairfield, Vic 3078, Australia
[2] Alfred Hosp, Dept Infect Dis, Prahran, Vic 3181, Australia
关键词
D O I
10.1086/516263
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical and bacteriologic features and clinical outcomes of culture-confirmed campylobacter bacteremia in 21 patients (including nine human immunodeficiency virus [HIV]-infected subjects and 12 non-HIV-infected subjects) were retrospectively evaluated and compared, This study highlights differences between HIV-infected and non-HIV-infected individuals, Campylobacter jejuni bacteremia in HIV-infected patients was found to often be a severe, debilitating febrile illness requiring multiple and prolonged courses of antibiotic therapy. Extraintestinal features, particularly pulmonary involvement, were often observed, Cellulitis occurred in one patient. By contrast, in non-HIV-infected patients, the illness was generally an acute onset of fever associated with self-limiting enteritis, with fever resolving rapidly with antibiotic treatment, Travel history (42% of cases) appeared to be a common risk factor in the latter group. Two of these patients had cutaneous manifestations, thus suggesting that some strains may be more invasive, This study suggests that campylobacter bacteremia is an important cause of morbidity and mortality in HIV-infected individuals; the overall mortality rate among HIV-infected patients with bacteremia in this study was 33%, This is not the case for immunocompetent patients, in whom death rarely occurs.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 30 条
[1]   DIARRHEA AND CAMPYLOBACTER INFECTIONS IN PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS [J].
BERNARD, E ;
ROGER, PM ;
CARLES, D ;
BONALDI, V ;
FOURNIER, JP ;
DELLAMONICA, P .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :143-144
[2]   EXTRAINTESTINAL CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI INFECTIONS - HOST FACTORS AND STRAIN CHARACTERISTICS [J].
BLASER, MJ ;
PEREZ, GP ;
SMITH, PF ;
PATTON, C ;
TENOVER, FC ;
LASTOVICA, AJ ;
WANG, WL .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) :552-559
[3]   CAMPYLOBACTER ENTERITIS [J].
BLASER, MJ ;
RELLER, LB .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (24) :1444-1452
[4]   USE OF AN IMMUNOGLOBULIN-M CONTAINING PREPARATION FOR TREATMENT OF 2 HYPOGAMMAGLOBULINEMIC PATIENTS WITH PERSISTENT CAMPYLOBACTER-JEJUNI INFECTION [J].
BORLEFFS, JCC ;
SCHELLEKENS, JF ;
BROUWER, E ;
ROZENBERGARSKA, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (10) :772-775
[5]   PERSISTENCE OF MULTIPLY ANTIBIOTIC-RESISTANT CAMPYLOBACTER-JEJUNI IN A PATIENT WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME [J].
DWORKIN, B ;
WORMSER, GP ;
ABDOO, RA ;
CABELLO, F ;
AGUERO, ME ;
SIVAK, SL .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (05) :965-970
[6]   FLUOROQUINOLONE RESISTANCE IN CAMPYLOBACTER SPP ISOLATED FROM HUMAN STOOLS AND POULTRY PRODUCTS [J].
ENDTZ, HP ;
MOUTON, RP ;
VANDERREYDEN, T ;
RUIJS, GJ ;
BIEVER, M ;
VANKLINGEREN, B .
LANCET, 1990, 335 (8692) :787-787
[7]   SUSCEPTIBILITIES OF FLUOROQUINOLONE-RESISTANT STRAINS OF CAMPYLOBACTER-JEJUNI TO 11 ORAL ANTIMICROBIAL AGENTS [J].
GOMEZGARCES, JL ;
COGOLLOS, R ;
ALOS, JI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :542-544
[8]   CAMPYLOBACTERIOSIS IN MAN - PATHOGENIC MECHANISMS AND REVIEW OF 91 BLOOD-STREAM INFECTIONS [J].
GUERRANT, RL ;
LAHITA, RG ;
WINN, WC ;
ROBERTS, RB .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (04) :584-590
[9]   ERYSIPELAS-LIKE SKIN-LESIONS ASSOCIATED WITH CAMPYLOBACTER-JEJUNI SEPTICEMIA IN PATIENTS WITH HYPOGAMMAGLOBULINEMIA [J].
KERSTENS, PJSM ;
ENDTZ, HP ;
MEIS, JFGM ;
OYEN, WJG ;
KOOPMAN, RJI ;
VANDENBROEK, PJ ;
VANDERMEER, JWM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (09) :842-847
[10]   USE OF AZITHROMYCIN FOR THE TREATMENT OF CAMPYLOBACTER ENTERITIS IN TRAVELERS TO THAILAND, AN AREA WHERE CIPROFLOXACIN RESISTANCE IS PREVALENT [J].
KUSCHNER, RA ;
TROFA, AF ;
THOMAS, RJ ;
HOGE, CW ;
PITARANGSI, C ;
AMATO, S ;
OLAFSON, RP ;
ECHEVERRIA, P ;
SADOFF, JC ;
TAYLOR, DN .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) :536-541